inVentiv Health plans to open a new Phase I/IIA clinic in Miami, expanding its Phase I clinical services into the U.S. The new clinic is expected to begin studies in 2H15. The new site compliments inVentiv’s clinical facility in Quebec, Canada.   The 65-bed Miami clinic, located in the University of Miami Life Science and Technology Park, will focus on studies including first-in-human Phase I, Phase I-in-patient and other Phase I trials such as drug-drug interaction, biosimilar, first-to-f...